Evidence map›Paper›PMID 20669245›Full record

ArticleMolecular nutrition & food research2011

Effects of the black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in vitro and in vivo.

Alexander Gosslau, David Li En Jao, Mou-Tuan Huang, Chi-Tan Ho, Dave Evans, Nancy E Rawson, Kuang Yu Chen

Open access · greenAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Dual action of epigallocatechin-3-gallate in virus-induced cell Injury.Journal, genetic engineering & biotechnology · 2023
    Article
  6. Article
  7. Article
  8. Green Tea Catechins: Nature's Way of Preventing and Treating Cancer.International journal of molecular sciences · 2022
    Review
  9. Life style and Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021
    Review
  16. Anti-Cancer Properties of Theaflavins.Molecules (Basel, Switzerland) · 2021
    Review
  17. Theaflavin Chemistry and Its Health Benefits.Oxidative medicine and cellular longevity · 2021
    Review
  18. Article
  19. Review
  20. Beneficial Properties of Green Tea Catechins.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alexander GosslauWellGen Inc., Commercialization Center for Innovative Technologies, North Brunswick, NJ 08854-8087, USA. agosslau@rutgers.edu
David Li En Jao
Mou-Tuan Huang
Chi-Tan Ho
Dave Evans
Nancy E Rawson
Kuang Yu Chen
Rutgers, The State University of New Jersey · US

Funding

Preclinical Evaluation of Black Tea ExtractsR43AT001143 · NCCIH · WELLGEN, INC. · PI EVANS, DAVID A · 2002 to 2002
$125k
NCCIH NIH HHS R43 AT001143
6 · The paper itself

Abstract

scopeTheaflavin-2 (TF-2), a major component of black tea extract, induces apoptosis of human colon cancer cells and suppresses serum-induced cyclooxygenase-2 (COX-2) expression 1. Here, we explored the mechanisms for activation of apoptosis, evaluated the impact on inflammatory genes in a broader panel of cells and tested whether topical anti-inflammatory effects could be observed in vivo. METHODS AND

resultsTF-2 triggered apoptosis in five other transformed cancer cell lines, inducing cell shrinkage, membrane blebbing, and mitochondrial clustering within 3 h of treatment. Among a set of pro-apoptotic genes, TF-2 quickly induced the up-regulation of P53 and BAX, suggesting mitochondria as the primary target. Using a cell model for inflammatory response, we showed that TF-2 suppressed the 12-O-tetradecanoylphorbol-13-acetate-induced COX-2 gene expression, and also down-regulated TNF-α, iNOS, ICAM-1, and NFκB. A reporter gene assay showed that TF-2 down-regulated COX-2 at the transcriptional level. We also demonstrated that TF-2 exhibited anti-inflammatory activity in two mouse models of inflammation. Topical application with TF-2 significantly reduced ear edema and produced a pattern of gene down-regulation similar to that observed in the cell model.

conclusionThese results suggest that the anti-inflammatory and pro-apoptotic activity of TF-2 may be exploited therapeutically in cancer and other diseases associated with inflammation.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalAntineoplastic Agents, PhytogenicApoptosisBiflavonoidsCatechinCell Line, TumorCell ProliferationCyclooxygenase 2DogsFemaleFlavonoidsGene Expression RegulationHumansInflammationInflammation MediatorsAnti-Inflammatory Agents, Non-SteroidalAntineoplastic Agents, PhytogenicBiflavonoidsCatechinCyclooxygenase 2FlavonoidsInflammation MediatorsRNA, MessengerTeatheaflavinTumor Suppressor Protein p53

Identifiers

PMID20669245
PMCPMC3033565
OpenAlexW2052683686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.